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Objectives: The use of pharmacoeconomic evaluations, e.g. cost-utility analysis 
(CUA), in resource allocation is gaining attention in Arabic –speaking countries. The 
Short Form-6D (SF-6D) is a generic preference-based measure of health-related 
quality of life (HRQoL) that can be used to generate health-state utilities for use in 
CUAs. The objective of this study is to translate and culturally-adapt the SF-6D for 
use in Arabic-speaking countries, with particular focus on Egypt and the United 
Arab Emirates. MethOds: The study followed the International Quality of Life 
Assessment (IQOLA) methodology. Two forward translations, one consensus and 
one backward translation were undertaken. The translators (professional linguists 
and bilingual pharmacoeconomists) reported the difficulties encountered in the 
translation process. An advisory committee of six researchers and three clini-
cians, who are native Arabic speakers and proficient in English language, assessed 
the consensus version for accuracy, cultural compatibility and cognitive burden. 
The difficulties encountered during the process were categorized as grammati-
cal, idiomatic, semantic/conceptual, and cultural. The backward translation was 
completed by a professional medical translator, reviewed and assessed by the com-
mittee. Results: Five items raised discussion during the process for grammatical 
(1 item), semantic (1 item), idiomatic (1 item) and cultural (2 items). For example, 
“emotional problems” had to be culturally adapted and “down-hearted and low” 
had to be substituted. The committee members approved the forward translation as 
linguistically and grammatically accurate. Minor changes were made to the forward 
translation to improve cultural appropriateness. The Backward translation did not 
reveal major problems and equivalence to the original was confirmed following 
committee review. cOnclusiOns: The translation and cultural adaptation of the 
SF-6D into Arabic resulted in a conceptually equivalent and culturally appropriate 
version. Psychometric validation and a valuation survey will be needed to assess 
its validity for use in the target populations.
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Objectives: Electronic formats of patient-reported outcome (PRO) measures 
are now routinely used in clinical trials. Their use promises a range of benefits 
such as improving access to patients, increasing compliance, reducing miss-
ing data and avoiding errors associated with data entry. When changing from 
paper and pen to an electronic administration it is necessary to establish their 
equivalence. This is the first study to evaluate the use of Rasch analysis for 
this purpose. MethOds: Three groups of US patients with pulmonary hyper-
tension participated. A clinical sample completed an electronic version of the 
CAMPHOR (e-sample) and two different samples completed the pen and paper 
administration (pp1 and pp2). Analyses were conducted on the CAMPHOR activity 
limitations and quality of life (QoL) scales. The three databases were analysed 
separately for fit to the Rasch model. Data were then combined, re-analysed and 
assessed for differential item functioning (DIF). Results: The three datasets 
were matched randomly for sample size (n= 147). Mean age (years) and percent-
age male respondents were as follows: e-sample (51.7, 16.0%); pp1 (50.0, 14.0%); 
pp2 (55.5, 40.4%). After minor adjustments to the three datasets, fit to the Rasch 
model was achieved (Chi2 values for activity limitations and QoL respectively 
were e-sample (0.11, 0.07); pp1 (0.18, 0.12); pp2 (0.40, 0.30)). Fit was also achieved 
for the combined sample after minor adjustments (activity limitations Chi2 = 
0.21, QoL Chi2 = 0.12). Importantly, no evidence of DIF by mode of administration 
was found. cOnclusiOns: Equivalence of the electronic and pen and paper 
administrations of the CAMPHOR was established. The results showed how the 
Rasch model can be utilized to determine the equivalence of alternative formats 
of PRO measures. This methodology has the added advantage of avoiding the 
need for complex study designs such as matching samples for disease severity 
or repeated administration of alternative formats of questionnaires.
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Objectives: Economic evaluation typically is conducted using health state 
utilities to estimate treatment benefits. However, such outcomes are often miss-
ing from studies of clinical effectiveness. This study aims to bridge that gap by 
providing appropriate methods to link values from the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) to the EQ-5D utility instru-
ment. MethOds: Patients from a large registry of Spanish patients (n= 7072 obser-
vations) with knee or hip osteoarthritis who completed both WOMAC and EQ-5D 
was used. A mixture model approach was used based on distributions bespoke to 
the EQ-5D UK value set to estimate EQ-5D as a function of WOMAC pain, stiffness 
and function subscores. Results: A five class mixture model provides very close 
fit to the observed data at all levels of disease severity. The overall mean (0.542 vs 
0.542), median (0.620 vs 0.636) and the percentage of observations at full health 
(15 vs 14.8) were very similar between the observed data and the estimated model 
respectively. Stiffness has limited relationship to EQ-5D, whereas functional disabil-
ity and pain are strong predictors. cOnclusiOns: EQ-5D can be reliably estimated 
from WOMAC subscale scores without any systematic bias using the results based 
on a bespoke mixture model method.
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ateness of the resulting test questionnaire. After revision, the pilot questionnaire 
was created. Results: Concepts elicited during group discussions revolved around 
pleasure and health. The test questionnaire consisted of 199 items divided into six 
modules: “grocery shopping”, “cooking”, “places where meals are eaten”, “convivial-
ity”, “eating and drinking”, and “eating habits and health”. Items within the first 
five modules assess subject behaviour and benefits (pleasure, psychology, digestion, 
physical condition); the module “eating habits and health” assesses beliefs. Cognitive 
interviews led to minor rewordings, removal and addition of items. The resulting pilot 
questionnaire consisted of 174 items distributed across the 6 aforementioned mod-
ules. cOnclusiOns: We developed a unique tool that comprehensively assesses the 
full picture of well-being related to food and eating habits in the general population. A 
validation study is underway to establish the scoring and ascertain the psychometrics 
of the instrument before it can be used in clinical studies.
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Lack of an established Polish terminology is a serious limitation of the development 
of health-related quality of life (HRQoL) studies in Poland. Objectives: To develop 
Polish dictionary of terms used in the studies of HRQoL. MethOds: In February 2012, 
HRQoL Special Interest Group of ISPOR Poland Chapter took on the task of preparing 
Polish dictionary of HRQoL terms. Following steps were planned: (1) preparation of 
a list of target English-language terms, (2) preparation of a reference list of transla-
tions typically used in Polish literature, (3) step-by-step translation of English terms 
by individual experts (4) analysis and approval of proposed translations by Expert 
Committee, (5) re-analysis of key terms, (6) preparation of pre-final vocabulary, (7) 
reviews by Review Committee, (8) preparation and publication of the final version. 
The list of English terms was based on following sources: popular English-language 
HRQoL textbooks, key words from papers published in leading peer-reviewed jour-
nals in the field, ISPOR guidelines concerning patient-reported outcomes, websites of 
generic HRQoL instruments. The reference lists of translations used in Polish literature 
was based on pharmacoeconomics and psychology textbooks, EBM dictionaries and 
HRQoL papers published in Polish peer-reviewed journals. Expert Committee was 
comprised of seven Polish investigators with vast experience in the field of HRQoL 
studies. Review Committee was formed by three authorities in the field of psycho-
metrics, statistics and epidemiology. Results: Till June 2013, there were 13 meetings 
of Expert Committee: three focused on the development of methodology and ten - on 
analysis and approval of proposed translations. Initially, we identified 1640 English 
terms from different sources. After removal of duplicates, final English list comprised 
of 1314 terms. Pre-final version of vocabulary, ready for peer-review, consists of 1051 
proposed Polish translations. cOnclusiOns: We anticipate, that dictionary prepared 
by the ISPOR Poland Chapter will support practical usage of PRO in Poland.
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Objectives: The lack of preference-based utility data places great importance 
on the accuracy of mapping functions. The objective of this study is to assess the 
predictive accuracy of statistical models which address the unique properties of 
EQ-5D. MethOds: A large dataset from the Patient Reported Outcome Measures 
(PROMs) programme reporting EQ-5D and OHS values for patients who have under-
gone total hip replacement, during April 2010 and March 2011, was used to develop 
6 mapping functions using different statistical methods: Ordinary Least Squares 
(OLS), standard Tobit, adjusted Tobit, two-part logit (TPL), response-mapping and 
censored least absolute deviation (CLAD). Three different model specifications 
were investigated, including the total OHS, individual item score and individual 
item responses. Each model specification was examined using goodness-of fit 
measures. The predictive accuracy of each model was analysed using the mean 
absolute error (MAE) and mean squared error (MSE). Model performance was com-
pared in an internal and external validation. Results: The OHS individual item 
response variables proved to give the best model fit and were therefore used 
across all models. The OLS and TPL models consistently demonstrated the highest 
predictive accuracy, providing the lowest MSE and the closest estimation of the 
mean EQ-5D. The response-mapping approach was the poorest predictor in esti-
mating individual values; however it was able to predict the median with perfect 
precision. Models using Tobit and CLAD frameworks provided the poorest predic-
tions. cOnclusiOns: The OLS and TPL models proved to be the most accurate 
in predicting EQ-5D on an individual level, whilst the response-mapping model 
is recommended for predicting the median. Using inaccurate mapping functions 
such as the Tobit models developed in this study can have a substantial impact 
on CEA results and reimbursement decisions.
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testing also provides preliminary quantitative item performance data and important 
insights about the usability of eDiaries.
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Objectives: In May 2013, the American Psychiatric Association released the fifth 
edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) which 
is a classification and diagnostic system for psychiatric and certain neurologic con-
ditions. DSM-5 brings significant changes to many of the diagnostic categories as 
compared to the previous edition of the manual. The objective of this review was 
to examine the changes in the Autism Spectrum Disorder (ASD) criteria and dis-
cuss the impact of these changes for industry. MethOds: A line-by-line review 
of the DSM-5 criteria for Autism Spectrum Disorder and the DSM-IV criteria for 
Pervasive Developmental Disorders was undertaken. Significant changes were 
highlighted and discussed from the point of view of sponsors of clinical trials for 
psychopharmacologic agents being developed to treat these conditions. Results: 
The changes to the diagnostic criteria for what were known in DSM-IV as pervasive 
developmental disorders (PDD) are sweeping. ASD, now in a section of the DSM 
titled “Neurodevelopmental Disorders,” is a single entity in DSM-5 with several 
levels of severity that effectively replaces the five PDDs that were separately clas-
sified in DSM-IV. Notable changes include the addition of severity levels to the ASD 
criteria, changes to the social interaction and social communication criteria, and 
the addition of hyper- or hyporeactivity to sensory input or unusual interest in sen-
sory aspects of the environment, as an illustrative example of restrictive, repetitive 
patterns of behavior, interests, or activities. cOnclusiOns: The numerous and 
significant changes in DSM-5 pose both challenges and opportunities to industry. We 
need to take a careful look at DSM-5 to understand what the changes mean for how 
we go about developing medical products to treat psychiatric disorders. This means 
the need for investment in research, education, and new ways of approaching the 
development of endpoints and outcome assessments in clinical trials.
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Objectives: The impact of addictive substance abuse (SA) on overall well-being, 
such as patient’s self-reported health status, may suffer from endogeneity bias. The 
purpose of this study is to estimate the impact of SA on patient’s health status using 
the instrumental variable (IV) approach. MethOds: The sample was extracted from 
the 2011 Substance Abuse and Mental Health Services Administration (SAMHSA) 
data for 36,347 adult US respondents who indicated SA status. Treating SA as exog-
enous, a single-equation probit model was used. Treating SA as endogenous, bivari-
ate probit models were employed using different IVs. The outcome variable was the 
self-reported health status (1= better than good; 0= fair or poor). Other exogenous 
variables controlled in the model were respondents’ age, gender, race, marital status, 
education level, employment status and family income. IVs were respondents’ age 
at SA initiation, SA frequency and substance availability. Exogeneity, over-iden-
tification and weak instrument tests were performed to ensure the validity and 
appropriateness of the IVs. Results: About 50% of the respondents were between 
18-25 years old. Over 56% indicated SA and approximately 36% had initiated SA 
before age 18. The single-equation probit suggested that SA was associated with 
at least a 2% decrease in overall health status (p< 0.01), compared those who never 
had SA. After adjusting for endogeneity bias, the negative relation between SA and 
health status increased by at least two-fold (p< 0.01). All tests indicated that the 
IVs used were valid and the results were significant. cOnclusiOns: The findings 
suggest that estimating the impact of SA on health status should consider adjust-
ing the endogeneity bias induced by individual characteristics and environmental 
factors such as age at SA initiation, frequency of SA use and substance availability 
in the community. Further investigations on the effect of SA abstinence durations 
on health status should be explored to strengthen their associations.
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Objectives: In May 2013, the American Psychiatric Association released the 
fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 
which is a classification system for psychiatric and certain neurologic conditions. 
DSM-5 brings significant changes to many diagnostic categories as compared to 
the previous edition of the manual. The objective of this review was to examine the 
changes in the Attention-Deficit/Hyperactivity Disorder (ADHD) criteria and discuss 
the impact these changes may have for industry. MethOds: A line-by-line review 
of the DSM-5 and DSM-IV criteria for ADHD was undertaken. Significant changes 
were highlighted and discussed from the point of view of sponsors of clinical trials 
for psychopharmacologic agents being developed to treat ADHD. Results: One of 
the more notable changes to ADHD criteria in DSM-5 is in the age of onset cutoff. 
To meet DSM-IV criteria, symptoms had to be present before age 7. In DSM-5 this 
was changed to 12. Additionally, symptoms present before the age of onset cutoff 
had to cause impairment to meet the DSM-IV criteria, but in DSM-5 there is no 
such requirement. Another significant change lies in the fact that while DSM-IV 
did not make a distinction between childhood and adult ADHD, in DSM-5, from 
age 17 on, only 5 of 9 symptoms in one or both categories are required, rather than 
6. Several other changes related to differential diagnosis and functional impair-
ment were noted as well. cOnclusiOns: The significant changes in DSM-5 pose 
Objectives: In the last years, the assessment of patient satisfaction has become 
an area of great interest due to its implications, especially in the management of 
chronic diseases. Across the board, satisfied patients tend to have better adher-
ence to medication. It affects a patient’s prognosis and treatment costs. High-risk 
hypertension and Diabetes Mellitus (DM) (types I and II) are two chronic diseases 
with high prevalence. The objective of this research was to examine Differential 
Item Functioning in a previously developed Satisfaction with Treatment item bank 
between these chronic diseases as a first step to improve the item bank. MethOds: 
The sample consisted of a total of 283 patients diagnosed with DM and 1.517 high or 
very high-risk hypertensive patients. Uniform DIF between both samples was inves-
tigated using Winsteps. The presence of DIF in thirteen items from a satisfaction 
bank was analyzed. Results: Ceiling effect was detected and an item-person map 
showed that the test was off-target and didn’t cover the highest range of the ability 
scale. DIF was present between patients with Diabetes Mellitus (I and II) and high-
risk hypertensive patients. Differences above one logit were found in three items, 
two related to adverse-events, which diabetes patients found harder to endorse, and 
one to oversights, harder to endorse for high-risk hypertensive patients. A differ-
ence in the same direction was found in two more items pertaining to convenience, 
with differences in this case larger than 0.75 logits. cOnclusiOns: This study 
represents a psychometrically valid initial effort to improve patients with chronic 
diseases satisfaction assessment. The DIF analysis has allowed improving the item 
satisfaction bank, selecting those items which could provide better information in 
order to develop a satisfaction questionnaire better tailored to specific patients. 
Future research is recommended considering different chronic pathologies and to 
reduce the ceiling effect associated with the satisfaction measures.
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Objectives: In May 2013, the American Psychiatric Association released the fifth 
edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), a 
classification system for psychiatric and certain neurologic conditions. DSM-5 
brings significant changes to many diagnostic categories as compared to the 
previous DSM-IV-TR. The objective of this review was to examine the changes 
in the Schizophrenia criteria and discuss the impact these changes may have 
for industry. MethOds: A line-by-line review of the DSM-5 and DSM-IV criteria 
was undertaken. Significant changes were highlighted and discussed from the 
point of view of sponsors of clinical trials for psychopharmacologic agents being 
developed to treat Schizophrenia. Results: The primary diagnostic criteria for 
Schizophrenia in DSM-5 are little changed. The major change in the so-called 
“active-phase symptoms” is with the mix of symptoms that can meet this crite-
rion. Five key symptom areas must be present to meet criteria. In DSM-IV, any two 
symptoms were sufficient and in some limited cases, even just one was enough 
(bizarre delusions or Schneiderian first-rank auditory hallucinations – convers-
ing voices). According to the DSM-5 criteria, there always must be at least two 
symptoms to meet Criterion A, and one of the two must be either delusions, hal-
lucinations, or disorganized speech. Other important changes include changes to 
the course specifiers, the elimination of Schizophrenia subtypes, and the addition 
of an optional framework for clinicians to rate the severity of the primary symp-
toms. cOnclusiOns: The changes in DSM-5 pose both challenges and opportu-
nities for industry. The changes in the DSM-5 criteria may translate into changes 
for how we go about developing medical products to treat psychiatric disorders, 
including Schizophrenia. There will need to be an investment in research and edu-
cation, and sponsors must examine the possibility of developing new endpoints 
and outcome assessments for use in clinical trials.
PRM181
the vAlue of Pilot testing PRo syMPtoM DiARies PRioR to conDucting 
cognitive DebRiefing inteRviews in chilDRen/ADolescents: 
quAlitAtive AnD quAntitAtive insights
Arbuckle R.1, Holloway L.1, Carson R.T.2, Dennee-Sommers B.3, Abetz-Webb L.1
1Adelphi Values, Bollington, UK, 2Forest Research Institute, Jersey City, NJ, USA, 3Endpoint 
Outcomes, Boston, MA, USA
Objectives: To pilot test daily electronic symptom diaries in pediatric chronic 
constipation (CC) and irritable bowel syndrome with constipation (IBS-C) for approx-
imately one week prior to cognitive debriefing interviews. MethOds: Separate 
child and parent eDiary measures of CC/IBS-C symptoms were developed based 
on concept elicitation interviews with children with CC/IBS-C and their parents. 
The eDiaries were completed by 36 children/adolescents (aged 6-17 years) with 
CC/IBS-C and 30 parents (of 6 month-11 year old children with CC/IBS-C) for 5-9 
days prior to cognitive debriefing. Children and parents were trained to use the 
eDiary and following the pilot test, children and parents were interviewed sepa-
rately about their experiences completing the eDiaries and the symptom items. 
Item descriptive statistics were calculated using the eDiary data collected during the 
pilot test. Results: Both eDiaries were well understood, all items were considered 
relevant, and no symptoms were identified as missing from the eDiaries. During 
cognitive debriefing, the children were able to reflect on their experiences of com-
pleting the eDiary as opposed to considering hypothetical scenarios to debrief the 
items. Although 9 children and 15 parents reported challenges with transmitting 
data, mean compliance rates were high (94% and 92%, respectively), indicating low 
levels of missing data and that the eDiaries were easy to use overall. Mean comple-
tion times were 3.72 minutes for children and 3.96 minutes for parents, provid-
ing further evidence of low burden. All item responses were normally distributed 
and demonstrated expected patterns of response (e.g., most reported 0 or 1 bowel 
movement daily). cOnclusiOns: Pilot testing eDiaries prior to cognitive debrief-
ing interviews, especially with children, provides respondents with the experience 
of completing the eDiary, facilitating a more informed qualitative interview. Pilot 
